Literature DB >> 18952304

Genetic epidemiology: the use of old and new tools for multiple sclerosis.

Sreeram V Ramagopalan1, David A Dyment, George C Ebers.   

Abstract

We review the practical application of the tools for studying the genetic epidemiology of complex disease. Whole-genome association studies highlight the need to understand the genetic epidemiology. Elucidating the genetic basis of disease anticipated from these studies has been incomplete, and the importance of the environment and its potential interaction with genes cannot be overlooked. Multiple sclerosis yields several key lessons including how epistatic effects might overshadow the small effects of genes identified from whole-genome association studies. We reinterpret twin studies and demonstrate the use and advantages of adoptee, half-sibling and avuncular-pair studies. These show that the environment acts at a population level, strongly indicating epigenetic modifications to germline susceptibility. There is good reason to think that such interactions will be within the major histocompatibility complex, in which strong epistatic effects have already been demonstrated. Family-based data in multiple sclerosis are applicable to other neurological traits.

Entities:  

Mesh:

Year:  2008        PMID: 18952304     DOI: 10.1016/j.tins.2008.09.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  13 in total

1.  Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. Characteristics of early (pre-1947) compared to later migrants.

Authors:  J G McLeod; S R Hammond; J F Kurtzke
Journal:  J Neurol       Date:  2011-09-23       Impact factor: 4.849

2.  Public health implications of epigenetics.

Authors:  Adam E Handel; Sreeram V Ramagopalan
Journal:  Genetics       Date:  2009-06-29       Impact factor: 4.562

3.  Mother-child blood group incompatibility and the risk of multiple sclerosis.

Authors:  Sreeram V Ramagopalan; David A Dyment; Colleen Guimond; Sarah-Michelle Orton; Irene M Yee; George C Ebers; A Dessa Sadovnick
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

4.  Congenital abnormalities and multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Colleen Guimond; Maria Criscuoli; David A Dyment; Sarah-Michelle Orton; Irene M Yee; George C Ebers; Dessa Sadovnick
Journal:  BMC Neurol       Date:  2010-11-16       Impact factor: 2.474

Review 5.  Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.

Authors:  Ani Grigorian; Haik Mkhikian; Carey F Li; Barbara L Newton; Raymond W Zhou; Michael Demetriou
Journal:  Semin Immunopathol       Date:  2012-04-11       Impact factor: 9.623

Review 6.  Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity.

Authors:  Manfred Kunz; Saleh M Ibrahim
Journal:  Mediators Inflamm       Date:  2009-10-26       Impact factor: 4.711

7.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

8.  Multiple linked quantitative trait loci within the Tmevd2/Eae3 interval control the severity of experimental allergic encephalomyelitis in DBA/2J mice.

Authors:  K M Spach; L K Case; R Noubade; C B Petersen; B McElvany; N Zalik; W F Hickey; E P Blankenhorn; C Teuscher
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

9.  Multiple sclerosis: major histocompatibility complexity and antigen presentation.

Authors:  Sreeram V Ramagopalan; George C Ebers
Journal:  Genome Med       Date:  2009-11-06       Impact factor: 11.117

10.  Multiple sclerosis pharmacogenetics: personalized approach towards tailored therapeutics.

Authors:  Iris Grossman; Ariel Miller
Journal:  EPMA J       Date:  2010-06-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.